BioBridgeXAll companies

E25Bio Inc.

Biotechnology company · Cambridge, Massachusetts, United States

E25Bio Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $1.8 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $500,000 sold in a notice filed in 2021.

www.e25bio.comProfile compiled from public records. Is this your company? Request a correction or update

E25Bio at a glance

Typebiotechnology company
HeadquartersCambridge, Massachusetts, United States
Earliest incorporation on record2018
Employees (self-reported, 2020)4
SEC CIK1786210

What does E25Bio do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $1.8 million in total (2019 to 2020). NIH funding came from the National Institute of Allergy and Infectious Diseases.

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $500,000 sold (2021).

Frequently asked questions about E25Bio

Where is E25Bio headquartered?

E25Bio Inc. is headquartered in Cambridge, Massachusetts, United States.

What does E25Bio do?

E25Bio Inc. is a biotechnology company.

When was E25Bio founded?

The earliest incorporation on record for E25Bio Inc. is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences